A Japanese health ministry proposal to impose steeper price cuts on certain medicines deemed to carry poor cost-effectiveness profiles cleared…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Price Gap between Long-Listed Products, Generics Should Be Retained: Mr Chikazawa of MHLW
September 28, 2012
-
BUSINESS Takeda Aims to Become No. 1 in Domestic Diabetes, Cardiovascular Markets: Senior Vice Pres. Iwasaki
September 27, 2012
-
BUSINESS Japan Vaccine Pres. Nagano Eyes One-Third Market Share or More in FY2020
September 26, 2012
-
BUSINESS Sanofi-Aventis Looks to Clinical Evidence to Differentiate Lantus from Rival
September 25, 2012
-
ORGANIZATION MHLW Reports Results of Analysis of “Close-Call” Incidents at Pharmacies with Generics
September 24, 2012
-
BUSINESS Pfizer Preparing for Assault on Domestic Generic Drug Market with Help from Mylan
September 24, 2012
-
REGULATORY MHLW to Introduce Brand Name Rules for Combination Injectables to Prevent Medical Accidents
September 21, 2012
-
ORGANIZATION Dr Fukuda Lays Out 4 Options for HTA Introduction in Drug Pricing
September 20, 2012
-
ORGANIZATION Maker FTC Bans Drink Donations at Academic Conferences
September 19, 2012
-
BUSINESS Chugai Provides All-Case PMS Data via iPad, Beginning with Avastin
September 18, 2012
-
BUSINESS JT Sees Silver Lining in Pharmaceutical Biz 25 Yrs after Market Entry; 1st Approval Obtained for Proprietary Drug
September 14, 2012
-
REGULATORY Osaka District Court to Issue Ruling on Actos Patent Suit on Sept. 27
September 12, 2012
-
BUSINESS Wholesalers Unlikely to See Significant Progress in Price Negotiations By End of September
September 12, 2012
-
BUSINESS Pharmaceutical Companies Beefing Up Training for Cancer Specialized MRs
September 11, 2012
-
BUSINESS DSP Revising Midterm Business Plan – Will It Be Able to Hammer Out Effective Measures against Stagnant Domestic Business?
September 10, 2012
-
BUSINESS Kissei Aims for 40% Market Share for Epoetin Alfa at Early Stage
September 7, 2012
-
BUSINESS Nippon Shinyaku Plans Generic Launch to Complement Its New Drug Lineup in Priority Field
September 6, 2012
-
BUSINESS Meiji Seika Pharma Aims to Bolster Presence with COPD Drug Oxis
September 5, 2012
-
BUSINESS RaQualia to Focus on Fields Where It Can Exhibit Uniqueness, Compile Biz Strategy in November
September 4, 2012
-
BUSINESS DSP’s US Subsidiary Sunovion to Acquire Elevation Pharmaceuticals of the US
September 3, 2012
ページ
A Japanese drug pricing panel on November 11 discussed ways to respond to the US most-favored-nation (MFN) policy, with healthcare…
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…